The test is useful for analysing learning abilities and memory. The patients who pass the test run a very low risk of developing dementia in the forthcoming three years. Those who perform below a certain threshold run a serious risk, even though other cognitive functions – language skills, mental agility, and the ability to perceive pattern, shape and position – might be normal. However, it is difficult to distinguish between high and low-risk patients when dealing with people with slightly impaired memories. In such cases, protein levels in the cerebrospinal fluid can help to sort out which ones are in the risk-zone.
The thesis also shows that concentrations of a certain protein in the cerebrospinal fluid rise in direct proportion to the deterioration of cognitive functions in people who develop Alzheimer’s disease. The study is the first in the world to reveal this correlation, which can help scientists to understand the mechanisms behind Alzheimer’s disease. The study is a response to people’s generally increasing memory concerns and was designed to produce a method that would enable doctors and psychologists to distinguish between treatable memory problems and nascent dementia.
Thesis: “Predictors of cognitive decline in memory clinic patients”, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet.
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
16.08.2017 | Physics and Astronomy
16.08.2017 | Materials Sciences
16.08.2017 | Interdisciplinary Research